Search
for

    Glossary Paclitaxel

    chemotherapy drug that inhibits cancer cell division

    Paclitaxel, also known by the brand name Taxol, is a chemotherapy medication used to treat various types of cancer, including breast, ovarian, and lung cancer. It works by inhibiting cell division, which prevents cancer cells from growing and spreading. This drug can cause side effects such as hair loss (alopecia), as it affects rapidly dividing cells, including those in hair follicles.

    Related Terms

    Research 10 of 598

    1. Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer 2009 · 61 citations
    2. Paclitaxel-loaded star-shaped copolymer nanoparticles for enhanced malignant melanoma chemotherapy against multidrug resistance Drug Design Development and Therapy · 2017 · 43 citations
    3. Minoxidil is a potential neuroprotective drug for paclitaxel-induced peripheral neuropathy Scientific Reports · 2017 · 28 citations
    4. Cardioprotective effect of royal jelly on paclitaxel-induced cardio-toxicity in rats. PubMed · 2016 · 24 citations
    5. First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study BMC Cancer · 2005 · 22 citations
    6. Ayurveda-based Botanicals as Therapeutic Adjuvants in Paclitaxel-induced Myelosuppression Frontiers in Pharmacology · 2022 · 12 citations
    7. Low Intensity Ultrasound as an Antidote to Taxane/Paclitaxel-induced Cytotoxicity Journal of Cancer · 2022 · 11 citations
    8. Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer Journal of Clinical Oncology · 2022 · 9 citations
    9. Noyes-Whitney Dissolution Model-Based pH-Sensitive Slow Release of Paclitaxel (Taxol) from Human Hair-Derived Keratin Microparticle Carriers BioMed research international · 2021 · 9 citations
    10. Taxane-induced alopecia: A historical review of patients with ovarian or breast cancer treated with with paclitaxel, docetaxel or paclitaxel poliglumex Journal of Clinical Oncology · 2005 · 5 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →